SCHEMBL4583410

SCHEMBL4583410

COc1ccc(C[C@](CN2C(=O)c3ccccc3C2=O)(NC(=O)O)C(C)(C)C)cc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
CASP3 P42574 1/20 0.47
NPC1 O15118 1/20 0.47
RPS6KA2 Q15349 2/20 0.45
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HSD17B10 Q99714 2/20 0.44
KMT2A Q03164 2/20 0.44
GAA P10253 1/20 0.44
MEN1 O00255 1/20 0.44
RAB9A P51151 1/20 0.43
NR1H3 Q13133 1/20 0.43
POLB P06746 1/20 0.42
APEX1 P27695 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4583697 0.90 KMT2A (0.48) ALDH1A1CASP3NPC1CYP3A4CYP2C9
SCHEMBL3724996 0.81 SMN1; SMN2 (0.37) NPC1HSD17B10KMT2AMEN1RAB9A
SCHEMBL4374678 0.79 KMT2A (0.47) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL1539533 0.79 KMT2A (0.39) NPC1HSD17B10KMT2AMEN1RAB9A
SCHEMBL4583741 0.78 MMP1 (0.43) NPC1KMT2AMEN1RAB9APOLB
SCHEMBL4374146 0.77 KMT2A (0.41) ALDH1A1NPC1KMT2AMEN1RAB9A
SCHEMBL4381679 0.76 MEN1 (0.47) ALDH1A1NPC1KMT2AGAAMEN1
SCHEMBL45154 0.69 CASP3 (0.88) CASP3KMT2AGAAMEN1
SCHEMBL30296449 0.69 CASP3 (0.88) CASP3KMT2AGAAMEN1
SCHEMBL3725498 0.68 KDM4E (0.51) ALDH1A1NPC1KMT2AMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1968568-A2 INHIBITORS OF Akt ACTIVITY SmithKline Beecham Corporation (US) 2008-09-17 EP disclosed
WO-2007076423-A2 INHIBITORS OF Akt ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2007-07-05 WO disclosed